Browse > Article
http://dx.doi.org/10.4062/biomolther.2008.16.4.364

Antihyperlipidemic Effects of Red Ginseng, Crataegii Fructus and Their Main Constituents Ginsenoside Rg3 and Ursolic Acid in Mice  

Min, Sung-Won (College of Pharmacy, Kyung Hee University)
Jung, Sang-Hyun (School of Korean Medicine, Kyung Hee University)
Cho, Ki-Ho (School of Korean Medicine, Kyung Hee University)
Kim, Dong-Hyun (College of Pharmacy, Kyung Hee University)
Publication Information
Biomolecules & Therapeutics / v.16, no.4, 2008 , pp. 364-369 More about this Journal
Abstract
Anti-hyperlipidemic effect of red ginseng (RG; the steamed root of Panax ginseng C.A. Meyer) and Crataegii fructus (CF, the fruit of Crataegus pinnatifida BGE), which are used frequently in China and Korea as herbal medicines to treat arteriosclerosis, were investigated. Treatments of RG and CF significantly reduced blood triglyceride (TG) and total cholesterol (TC) levels in Triton WR-1339-induced hyperlipidemic mice and serum TG levels in corn oil-induced hypertriglyceridemic mice. Ginsenoside Rg3 and ursolic acid, the main constituents of RG and CF, respectively, also reduced TG and TC levels in hyperlipidemic mice. RG and CF significantly lowered the high blood TG and TC levels and body and epididymal mass weights induced by long-term feeding of a high-fat diet and increased the high-fat diet-induced decrease in blood HDL cholesterol levels. RG and Rg3 reduced the blood TC levels more than CF and ursolic acid. However, blood TG level were reduced by CF and ursolic acid more than RG and Rg3. RG, CF, and their constituents also inhibited pancreatic lipase and HMG-CoA reductase activities. The most potent inhibitor was Rg3. These findings suggest that RG and CF may be suitable for the therapies of hypercholesterolemia and triglyceridemia, respectively.
Keywords
Red ginseng; Crataegus pinnatifida; Hyperlipidemia; Pancreatic lipase; HMG-CoA reductase; Ginsenoside Rg3; Ursolic acid;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 5  (Related Records In Web of Science)
Times Cited By SCOPUS : 6
연도 인용수 순위
1 Chang, W. T., Dao, J., Shao, Z. H. (2005). Hawthorn: potential roles in cardiovascular disease. Am. J. Chin. Med. 33, 1-10   DOI   ScienceOn
2 Davidson, M. H. (2003). Ezetimibe: a novel option for lowering cholesterol. Expert. Rev. Cardiovasc. Ther. 1, 11-21   DOI   ScienceOn
3 Ballinger, A. (2000). Orlistat in the treatment of obesity. Expert. Opin. Pharmacother. 1, 841-847   DOI   ScienceOn
4 Carey, M. C., Small, D. M. and Bliss, C. M. (1993). Lipid digestion and absorption. Annu. Rev. Physiol. 45, 651-677   DOI   ScienceOn
5 Meigs, T. E., Roseman, D. S. and Simoni, R. D. (1996). Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. J. Biol. Chem. 271, 7916-7922   DOI
6 Thomson, A. B., Schoeller, C., Keelan, M., Smith, L. Clandinin M. T. (1993). Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Can. J. Physiol. Pharmacol. 71, 531-555   DOI   ScienceOn
7 Edwards, P. A., Lemongello, D. and Kane, J. (1980). Properties of purified rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and regulation of enzyme activity. J. Biol. Chem. 255, 3715-3725
8 Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W. and Fu, P. C.(1974). Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470-475
9 Bae, E. A., Han, M. J., Choo, M. K., Park, S. Y. and Kim, D. H.(2002). Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 25, 58-63   DOI   ScienceOn
10 Edwards, P. A., Lemongello, D. and Fogelman, A. M. (1979). Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Lipid Res. 20, 40-46
11 Endo, A. (1992). The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569-1582
12 Goldstein, J. L., Schrott, H., Hazzard, E., Bierman, E. and Motuski, A. (1973). Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest. 52, 1544-1568   DOI
13 Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49, 57-68   DOI
14 Heber, D. (2001). Herbs and atherosclerosis. Curr. Atheroscler. Rep. 3, 93-96   DOI
15 Ia Cour, B., Molgaard, P., Yi, Z. (1995). Traditional Chinese medicine in treatment of hyperlipidaemia. J. Ethnopharmacol. 46, 125-129 (1995)   DOI   ScienceOn
16 Inoue, M., Wu C.Z., Dou D.Q., Chen Y.J., Ogihara Y. (1999). Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals. Phytomedicine 6, 257-265   DOI   ScienceOn
17 Thompson Coon J. S. and Ernst E. (2003). Herbs for serum cholesterol reduction: a systematic view. J. Fam. Pract. 52, 468-478
18 Trinh, H. T., Han, S. J., Kim, S. W., Lee, Y. C. and Kim, H. D. (2007). Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J. Microbiol. Biotechnol. 17, 1127-1133   과학기술학회마을
19 Zhou, L., Zuo, Z. and Chow, M. S. (2005). Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45, 1345-1359   DOI
20 Kusama, H., Nishiyama, M. and Ikeda, S. (1988). Pharmacological investigation of bezafibrate, a hypolipidemic agent (1). Effects of bezafibrate on normal and experimental hyperlipidemia in rats. Folia Pharmacol. Jpn. 92, 175-180   DOI
21 White, L. W. and Rudney, H. (1970). Regulation of 3-hydroxy-3-methylglutarate and mevalonate biosynthesis by rat liver homogenates. Effects of fasting, cholesterol feeding, and triton administration. Biochemistry 9, 2725-2731   DOI   ScienceOn
22 Sardesai V.M. and Mannig J.A., The determination of triglycerides in plasma and tissues. Clin. Chem. 14, 156-158
23 Duhault, J., Boulanger, M., Beregi, L., Sicot, N., Bouvier, F. (1976). 780 SE: a new type of hypolipemic agent. Atherosclerosis, 23, 63-72   DOI
24 Espenshade P. J., Hughes A. L. (2007). Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 41, 401-427   DOI   ScienceOn
25 Birari, R. B. and Bhutani, K. K. (2007). Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discovery Today 12, 879-889   DOI   ScienceOn
26 Heller, R. A. and Shrewsburg, M. A. (1976). 3-Hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. Its purification, properties, and immunochemical studies. J. Biol. Chem. 251, 3815-3822
27 Kim H. Y., Jeong da, M., Jung, H. J., Jung, Y. J., Yokozawa, T. and Choi, J. S. (2008). Hypolipidemic effects of Sophora flavescens and its constituents in poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Biol. Pharm. Bull. 31, 73-78   DOI   ScienceOn